89bio Inc Stock Price on November 27, 2024
| ETNB Stock | USD 8.04 0.04 0.50% |
Below is the normalized historical share price chart for 89bio Inc extending back to November 11, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of 89bio stands at 8.04, as last reported on the 11th of December 2024, with the highest price reaching 8.15 and the lowest price hitting 7.92 during the day.
If you're considering investing in 89bio Stock, it is important to understand the factors that can impact its price. At this point, 89bio is somewhat reliable. 89bio Inc secures Sharpe Ratio (or Efficiency) of 0.0178, which signifies that the company had a 0.0178% return per unit of volatility over the last 3 months. We have found twenty-three technical indicators for 89bio Inc, which you can use to evaluate the volatility of the entity. Please confirm 89bio's Market Risk Adjusted Performance of 0.0051, variance of 17.04, and Mean Deviation of 2.8 to double-check if the risk estimate we provide is consistent with the expected return of 0.0743%.
At present, 89bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 61.6 K, whereas Sale Purchase Of Stock is forecasted to decline to about 254.6 K. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.18, whereas Price Earnings Ratio is forecasted to decline to (5.87). 89bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of November 2019 | 200 Day MA 9.0091 | 50 Day MA 8.3378 | Beta 0.978 |
89bio |
Sharpe Ratio = 0.0178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ETNB | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.18 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average 89bio is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 89bio by adding it to a well-diversified portfolio.
Price Book 2.4878 | Book Value 3.563 | Enterprise Value 558 M | Enterprise Value Ebitda (2.75) | Shares Float 68.2 M |
Related Headline
Vericel Corp Headline on 27th of November 2024
Pharmaceutical Executive announces winners of 2024 Pharmaceu... by finance.yahoo.com
CRANBURY, N.J., Nov. 27, 2024 -- Its an appointment with excellence The Pharmaceutical Executive APEX Awards, the only advertising awards program judged exclusively by doctors, nurses and other health care heroes, proudly announced winners of its 2024 competition. This year, 30 industry leaders and globally recognized creative agencies participated, sharing campaigns that upraised therapies, treatment options, institutions and other breakthroughs to advance human health. Wer
89bio Valuation on November 27, 2024
It is possible to determine the worth of 89bio on a given historical date. On November 27, 2024 89bio was worth 8.93 at the beginning of the trading date compared to the closed value of 9.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of 89bio stock. Still, in general, we apply an absolute valuation method to find 89bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of 89bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against 89bio's related companies.
| Open | High | Low | Close | Volume | |
| 8.97 | 9.15 | 8.66 | 8.90 | 374,831 | |
11/27/2024 | 8.93 | 9.18 | 8.77 | 9.14 | 354,322 |
| 9.14 | 9.20 | 8.93 | 8.99 | 314,218 |
| Backtest 89bio | | | 89bio History | | | 89bio Valuation | Previous | Next |
89bio Trading Date Momentum on November 27, 2024
| On November 29 2024 89bio Inc was traded for 8.99 at the closing time. The top price for the day was 9.20 and the lowest listed price was 8.93 . The trading volume for the day was 314.2 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.64% . The daily price change against the current closing price is 7.66% . |
89bio Inc Fundamentals Correlations and Trends
By evaluating 89bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among 89bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. 89bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About 89bio Stock history
89bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 89bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in 89bio Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing 89bio stock prices may prove useful in developing a viable investing in 89bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 71.2 M | 74.7 M | |
| Net Loss | -91.8 M | -96.4 M |
89bio Quarterly Net Working Capital |
|
89bio Stock Technical Analysis
89bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
89bio Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
89bio Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
89bio December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how 89bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 89bio shares will generate the highest return on investment. By undertsting and applying 89bio stock market strength indicators, traders can identify 89bio Inc entry and exit signals to maximize returns
89bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for 89bio's price direction in advance. Along with the technical and fundamental analysis of 89bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of 89bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0078 | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |